In-vitro- und In-situ-Analyse des Tumorsuppressorgens hp19 ARF in malignen Melanomen
Lack of hp19ARF (=p14ARF) expression or its functional inactivation has been observed in human and murine carcinomas. Although very few mutations of hp19ARF have been detected in some cancer types, changes in expression seem to play an important role in the development of other human cancers such as mesotheliomas. To examine the hp19ARF gene and expression of hp19ARF protein in melanomas, we screened eight human melanoma cell lines and primary human melanocytes by RT-PCR, sequencing and immunoblotting. All melanoma cell lines analyzed expressed wild-type hp19ARF mRNA as well as protein. Hp19ARF expression was investigated by immunohistochemical staining of 32 tissue samples of benign melanocytic nevi (n=14), melanomas (n=12) and melanoma metastases (n=6). In contrast to the results obtained from cell lines in vitro the immunohistochemical stainings revealed a correlation between the progression of melanoma and the lack of the hp19ARF protein expression. Positive hp19ARF protein staining was observed in 11 of 14 benign nevi, in 3 of 12 melanomas and in 0 of 6 melanoma metastases. In summary, we demonstrated a significant inverse correlation between hp19ARF protein expression and progression of melanocytic tumors since the amount of hp19ARF protein staining decreased from benign melanocytic nevi to metastatic melanoma in situ. These results suggest that hp19ARF inactivation is important in the development of melanomas.
info:eu-repo/classification/ddc/610, Medizin, melanom, hp19arf, p14arf, p16
Networked Digital Library of Theses and Dissertations
Publikationsserver der RWTH Aachen University